Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 201,000 | 180,000 | 185,000 | 159,000 | 150,000 |
| Cost of Goods | 30,000 | 32,000 | 23,000 | 33,000 | 18,000 |
| Gross Profit | 171,000 | 148,000 | 162,000 | 126,000 | 132,000 |
| Operating Expenses | 98,000 | 91,000 | 172,000 | 108,000 | 107,000 |
| Operating Income | 73,000 | 57,000 | -10,000 | 18,000 | 25,000 |
| Interest Expense | 8,000 | 6,000 | 7,000 | 6,000 | 7,000 |
| Other Income | 1,000 | 2,000 | 2,000 | 1,000 | 2,000 |
| Pre-tax Income | 66,000 | 53,000 | -15,000 | 13,000 | 20,000 |
| Income Tax | 4,000 | -27,000 | 1,000 | 3,000 | -1,000 |
| Net Income Continuous | 62,000 | 80,000 | -16,000 | 10,000 | 21,000 |
| Net Income | $62,000 | $80,000 | $-16,000 | $10,000 | $21,000 |
| EPS Basic Total Ops | 0.40 | 0.55 | -0.05 | 0.05 | 0.10 |
| EPS Basic Continuous Ops | 0.42 | 0.54 | -0.09 | 0.05 | 0.14 |
| EPS Diluted Total Ops | 0.40 | 0.50 | -0.07 | 0.05 | 0.12 |
| EPS Diluted Continuous Ops | 0.40 | 0.51 | -0.11 | 0.05 | 0.14 |
| EBITDA(a) | $80,000 | $62,000 | $-4,000 | $24,000 | $30,000 |